Disparities in smoking cessation among U.S. adults with a history of asthma

[Smoking cessation in asthmatic patients and its impact]

INTRODUCTION

The prevalence of smoking in asthmatic patients is similar to, or even higher than in the general population.

OBJECTIVES

This systematic review addresses (1) the effects of smoking on asthma, (2) smoking cessation strategies in asthmatic patients, and (3) the consequences of smoking cessation for people with asthma.

RESULTS

Active or passive smoking can promote the development of asthma. The few studies on smoking cessation in asthma confirm the efficacy of validated smoking cessation strategies in these patients (nicotine replacement therapy, varenicline, bupropion, cognitive and behavioural therapies). Smoking cessation in parents with asthmatic children is essential and is based on the same strategies. Electronic cigarettes may be a useful help to quit smoking in some patients. Smoking cessation is beneficial in asthmatic smokers and associated with (1) a reduction of asthma symptoms, acute exacerbations, bronchial hyperresponsiveness, and bronchial inflammation, (2) decreased use of rescue medications and in doses of inhaled corticosteroids, (3) improved asthma control, quality of life, and lung function.

CONCLUSION

In asthmatic patients, it is essential to assess smoking status and health professionals must assist them to quit smoking.

Degrees of health disparities: Health status disparities between young adults with high school diplomas, sub-baccalaureate degrees, and baccalaureate degrees

Community colleges have increased post-secondary educational access for disadvantaged youth, but it is unknown how community college degrees fit into the educational gradient of health status disparities. Using data from high school graduates in the National Longitudinal Study of Adolescent Health, we compared young adults ages 26-31 whose highest degrees were high school diplomas (n=5584), sub-baccalaureate credentials (sub-BAs include community college certificates and associate's degrees) (n=2415), and baccalaureate degrees (BAs) (n=3303) on measures of hypertension, obesity, smoking, sleep problems, dyslipidemia, and depression. Comparisons used multivariate Poisson regression with robust standard errors after exact and nearest-neighbor Mahalanobis matching within propensity score calipers on 23 baseline factors measured in 1995. High school graduates and sub-BAs differed significantly on 3 of 23 baseline factors. After matching, sub-BAs were 16% less likely to smoke daily than if they had only a high school diploma but did not differ in other health status measures. Sub-BAs and BAs differed significantly on 14 of 23 baseline factors. After matching, BAs were 60% less likely to smoke daily, 14% less likely to be obese, and 38% less likely to have been diagnosed with depression. Sub-BA degrees are accessible to high school graduates irrespective of academic backgrounds and predict lower smoking prevalence. BAs are less accessible to high school graduates and predict lower chances of smoking, depression, and obesity.

Smoking and nonsmoking asthma: differences in clinical outcome and pathogenesis

Cigarette smoking in asthma is frequently present and is associated with worsening of symptoms, accelerated lung-function decline, a higher frequency of hospital admissions, a higher degree of asthma severity, poorer asthma control and reduced responsiveness to corticosteroids. Furthermore, it is associated with reduced numbers of eosinophils and higher numbers of mast cells in the submucosa of the airway wall. Airway remodeling is increased as evidenced by increased epithelial thickness and goblet cell hyperplasia in smoking asthmatics. The pathogenesis responsible for smoking-induced changes in airway inflammation and remodeling in asthma is complex and largely unknown. The underlying mechanism of reduced corticosteroid responsiveness is also unknown. This article discusses differences between smoking and nonsmoking asthmatics regarding the clinical expression of asthma, lung function, response to corticosteroids, airway inflammation and remodeling processes. Possible pathogenetic mechanisms that may explain the links between cigarette smoking and changes in the clinical expression of asthma will be discussed, as well as the beneficial effects of smoking cessation.

Challenges of treating asthma in people who smoke

Cigarette smoking is common in asthma and is associated with poor symptom control and a reduced therapeutic response to inhaled and oral corticosteroids as compared with nonsmokers with asthma. This review examines the range of adverse health effects of smoking in asthma, the inflammatory mechanisms that may influence the efficacy of current drugs and discusses potential future therapeutic directions.